WO2002026216A8 - Preparation pharmaceutique a base d'oxans - Google Patents

Preparation pharmaceutique a base d'oxans

Info

Publication number
WO2002026216A8
WO2002026216A8 PCT/FR2001/002980 FR0102980W WO0226216A8 WO 2002026216 A8 WO2002026216 A8 WO 2002026216A8 FR 0102980 W FR0102980 W FR 0102980W WO 0226216 A8 WO0226216 A8 WO 0226216A8
Authority
WO
WIPO (PCT)
Prior art keywords
oxan
preparation
pharmaceutical
pharmaceutically acceptable
combination
Prior art date
Application number
PCT/FR2001/002980
Other languages
English (en)
Other versions
WO2002026216A1 (fr
Inventor
Joel Bougaret
Laurent Liorzou
Michel Sournac
Original Assignee
Pf Medicament
Joel Bougaret
Laurent Liorzou
Michel Sournac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament, Joel Bougaret, Laurent Liorzou, Michel Sournac filed Critical Pf Medicament
Priority to US10/381,801 priority Critical patent/US20040022834A1/en
Priority to JP2002530046A priority patent/JP2004509916A/ja
Priority to CA002424949A priority patent/CA2424949A1/fr
Priority to EP01972214A priority patent/EP1322298A1/fr
Priority to AU2001292001A priority patent/AU2001292001A1/en
Publication of WO2002026216A1 publication Critical patent/WO2002026216A1/fr
Publication of WO2002026216A8 publication Critical patent/WO2002026216A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Préparation pharmaceutique topique, caracterisée en ce qu'elle est constituée par l'association d'un oxan et d'un excipient pharmaceutiquement acceptable permettant l'administration transdermique dudit oxan.
PCT/FR2001/002980 2000-09-26 2001-09-26 Preparation pharmaceutique a base d'oxans WO2002026216A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US10/381,801 US20040022834A1 (en) 2000-09-26 2001-09-26 Pharmaceutical oxan preparation
JP2002530046A JP2004509916A (ja) 2000-09-26 2001-09-26 オキサンに基づく薬剤
CA002424949A CA2424949A1 (fr) 2000-09-26 2001-09-26 Preparation pharmaceutique a base d'oxans
EP01972214A EP1322298A1 (fr) 2000-09-26 2001-09-26 Preparation pharmaceutique a base d'oxans
AU2001292001A AU2001292001A1 (en) 2000-09-26 2001-09-26 Pharmaceutical oxan preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0012197A FR2814368B1 (fr) 2000-09-26 2000-09-26 Preparation pharmaceutique a base d'oxans
FR0012197 2000-09-26

Publications (2)

Publication Number Publication Date
WO2002026216A1 WO2002026216A1 (fr) 2002-04-04
WO2002026216A8 true WO2002026216A8 (fr) 2003-01-16

Family

ID=8854662

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2001/002980 WO2002026216A1 (fr) 2000-09-26 2001-09-26 Preparation pharmaceutique a base d'oxans

Country Status (7)

Country Link
US (1) US20040022834A1 (fr)
EP (1) EP1322298A1 (fr)
JP (1) JP2004509916A (fr)
AU (1) AU2001292001A1 (fr)
CA (1) CA2424949A1 (fr)
FR (1) FR2814368B1 (fr)
WO (1) WO2002026216A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
ES2466647T3 (es) * 2006-05-08 2014-06-10 Teikoku Seiyaku Co., Ltd. Preparación absorbible por vía transdérmica que comprende un agente contra la demencia
JP6654365B2 (ja) * 2015-06-17 2020-02-26 日東電工株式会社 貼付製剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698789B1 (fr) * 1992-12-07 1995-03-03 Pf Medicament Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
DE4301783C1 (de) * 1993-01-23 1994-02-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil
FR2706303B1 (fr) * 1993-06-18 1995-09-08 Pf Medicament Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.
US5635204A (en) * 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation
US5879701A (en) * 1997-02-28 1999-03-09 Cygnus, Inc. Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
FR2801786B1 (fr) * 1999-12-01 2002-03-01 Fabre Pierre Cosmetique Nouvelles compositions topiques a base d'idazoxan et de cafeine ou de ses derives solubles et leur utilisation comme amincissant et/ou dans le traitement de la cellulite

Also Published As

Publication number Publication date
CA2424949A1 (fr) 2002-04-04
EP1322298A1 (fr) 2003-07-02
US20040022834A1 (en) 2004-02-05
WO2002026216A1 (fr) 2002-04-04
JP2004509916A (ja) 2004-04-02
FR2814368A1 (fr) 2002-03-29
FR2814368B1 (fr) 2004-05-07
AU2001292001A1 (en) 2002-04-08

Similar Documents

Publication Publication Date Title
AU2002239282A1 (en) Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
HK1059573A1 (en) Olopatadine formulations for topical administration.
PL362690A1 (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
AU2002241173A1 (en) Medicament dispenser with authentication
AU2001291159A1 (en) Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications
WO2001095899A3 (fr) Compositions pharmaceutiques renfermant des derives de cannabidiol
AU2001264887A1 (en) Drug delivery device
WO2000041681A3 (fr) FORMULATIONS DE MEDICAMENTS CONTENANT UN OPIOIDE ET UN α-AGONISTE
AU2002353444A1 (en) Integrated transdermal drug delivery system
ZA200200743B (en) Preserved pharmaceutical formulations.
AU2682401A (en) Flavonoid drug and dosage form, its production and use
AU2002236647A1 (en) Method and device for administering medication and/or placebo
AU2001266338A1 (en) Pharmaceutical compositions for angiogenic therapy
AU2003293593A8 (en) Pharmaceutical preparations, use of said preparations and method for increasing the bioavailability of medicaments for peroral administration
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
MXPA02001631A (es) Composiciones farmaceuticas para administracion oral y topica.
AU2001270963A1 (en) Transdermal drug delivery system
WO2002011724A3 (fr) Compositions de 2-pyridinamine et procedes associes
WO2002012198A3 (fr) Derives 4-pyrimidinamines, compositions pharmaceutiques et procedes associes
AU2001243515A1 (en) Combination drug therapy
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
WO2002026216A8 (fr) Preparation pharmaceutique a base d'oxans
AU2001258442A1 (en) Drug delivery device, especially for the delivery of levonorgestrel
EP1273301A3 (fr) Préparations pharmaceutiques comprenant des principes actifs susceptibles d'administration illicite
AU2002222138A1 (en) Drug delivery system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CA CN JP MX US ZA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 14/2002 UNDER (30) REPLACE "20000929" BY "20000926"

WWE Wipo information: entry into national phase

Ref document number: 2424949

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002530046

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001972214

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001972214

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10381801

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2001972214

Country of ref document: EP